PDL Practice Alert
Transitions of care
Transitions of care are pivotal moments in healthcare delivery, where patients move between different healthcare settings Whether transitioning from hospital to home, or from home to an aged-care facility …
Raising awareness of RSV vaccine options, midazolam and Wegovy strengths
PDL has some advice on RSV vaccination, and the strengths of midazolam and Wegovy This Practice Alert highlights some recent practice issues reported to PDL Professional Officers. Respiratory Syncytial Virus …
Have you received an Aphra notification?
During your healthcare career, you may receive a regulatory notification Regulatory notifications are a mechanism for the public to raise any concerns about their healthcare experience and are an integral …
Schedule 3 supply of therapeutic vaping products
From 1 October 2024, therapeutic vapes with a nicotine concentration of 20mg/mL or less will be available in pharmacies to patients 18 years or over without a prescription. Date of …
NSW Pharmaceutical Services Unit e-cigarette Compliance Program
PDL has some advice for pharmacists on lawfully supplying vapes for smoking cessation Pharmacists would be aware of the down scheduling of some nicotine vaping or e-cigarette products to S3 …
Pharmacists and the pill: advice on changes
PDL has advice for pharmacists in NSW and the ACT providing the oral contraceptive resupply service NSW pharmacists The oral contraceptive resupply component of the NSW Pharmacy Trial ceased on …
Be aware or beware of wrong patient errors – part 2
This alert provides insights into the common causes of wrong patient incidents and provides suggestions preventative strategies PDL has recently released the Practice Alert ‘Be aware or beware of wrong …
Administration of medicines by pharmacists in South Australia
PDL has advice for South Australian pharmacists about the recent change relating to administering medicines Following the recent direction from the chief pharmacist department of Health SA, PDL advises that …
Confusion with Wegovy prescriptions
PDL offers advice for pharmacists regarding Wegovy (semaglutide) following a number of incident reports Pharmacists are likely aware that Wegovy (semaglutide) is now available in Australia. The PDL Professional Officers …
Be aware or beware of wrong patient errors – part 1
The wrong patient incident type is a subset of dispensing incidents that continue to be highly reported to PDL This almost entirely preventable error occurs primarily in community pharmacies; …
New features in SafeScript
As of 16 August, SafeScript has introduced updated features designed to enhance the user experience The update that relates to pharmacists is the improved visibility of high-risk messages which now …
UTI service mandatory directory listing
Pharmacies in NSW providing a UTI service must meet the requirements of the authority Under this authority, pharmacies are required to maintain an up-to-date UTI service listing on the National …